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S1. Recoveries of OMPs in the solid and liquid phase of raw and digested sludge 
Table S1. Absolute recoveries (mean and average error) in the liquid and solid phase of 
sewage sludge (SS), mesophilic (MAD) and thermophilic (TAD) digestates. 
 
 Sludge matrix 
Recovery (%) 








ERY SS-MAD-TAD 62.0 ± 7.2 51.4 ± 8.2 
ROX 
SS 46.2 ± 0.1 
54.6 ± 2.8 
MAD-TAD 16.0 ± 2.8 
SMX 
SS 86.2 ± 3.2 
54.7 ± 6.9 MAD 74.0 ± 0.7 
TAD 57.3 ± 3.2 
TMP 
SS 70.7 ± 1.0 54.2 ± 3.9 
MAD 60.6 ± 0.9 
42.2 ± 5.7 
TAD 45.8 ± 2.4 
FLX 
SS 30.5 ± 2.3 44.4 ± 0.6 
MAD-TAD 8.3 ± 2.3 18.3 ± 3.2 
CTL 
SS 18.3 ± 0.4 53.3 ± 1.1 
MAD-TAD 9.3 ± 0.8 36.9 ± 4.7 
CBZ 
SS 84.8 ± 3.4 
63.8 ± 3.5 MAD 77.0 ± 1.3 
TAD 70.2 ± 1.4 
DZP 
SS 22.9 ± 0.5 
68.7 ± 7.1 
MAD-TAD 10.3 ± 0.6 
E1 
SS 22.9 ± 0.3 
67.8 ± 6.6 
MAD-TAD 13.1 ± 1.3 
E2 
SS 59.8 ± 2.8 
63.3 ± 6.3 
MAD-TAD 16.3 ± 4.3 
EE2 
SS 57.3 ± 0.6 
70.1 ± 7.7 MAD 34.3 ± 1.5 






ADBI SS-MAD-TAD 11.9 ± 3.3 168 ± 28 
HHCB SS-MAD-TAD 22.8 ± 13.1 159 ± 26 
AHTN SS-MAD-TAD 35.1 ± 14.9 189 ± 8 
IBP SS-MAD-TAD 163 ± 17 178 ± 11 
NPX 
SS 
194 ± 9 
133 ± 1 
MAD-TAD 88.8 ± 8.2 
DCF SS-MAD-TAD 141 ± 19 134 ± 10 
OP SS-MAD-TAD 11.1 ± 0.8 135 ± 32 
NP 
SS 
8.4 ± 4.5 
146 ± 11 
MAD-TAD 80.2 ± 13.8 
TCS SS-MAD-TAD 12.1 ± 1.5 151 ± 20 
4 
In general, the recoveries in the solid phase were quite similar regardless the matrix and, 
hence, average values were used in the calculations (Table S1). Nevertheless, FLX, CTL, 
NP, NPX, TMP presented a higher recovery in the mixed sewage sludge than in the 
digested. Ternes et al. (2005), whose USE extraction protocol was adapted in the present 
study, also observed this tendency for some OMPs. Sludge recoveries were generally 
above 50%, although some OMPs measured by GC-MS presented recoveries higher than 
100%, due to the presence of interfering substances in the chromatogram. In comparison 
with the methodology of Ternes et al. (2005), the recoveries of CBZ and DZP were 
improved, while those of IBP, DCF, AHTN, and HHCB were lower.  
The recoveries of some OMPs in the liquid phase were quite low, especially in the case 
of hydrophobic compounds. This fact could be related to the presence of colloids in the 
liquid phase, which hinders enormously the filtration process (Bivins and Novak, 2001) 
and hence decreased the recovery of OMPs. Likewise, the different concentration of 
colloids in the matrixes (TAD > MAD >> SS) (Bivins and Novak, 2001) could explain 
the general tendency observed in liquid recoveries: TAD < MAD << SS. In fact, FLX, 
CTL, ROX, DZP, E1 and E2 presented higher recoveries in the liquid SS matrix than in 
the digestates, while for SMX, TMP, CBZ and EE2 the differences between the three 
matrixes were significant. 
The relative standard deviations (RSD) of the solid phase recoveries were under 20% for 
all compounds, except for OP (24%), which indicates that the overall precision and 
repeatability of the method was quite good and comparable to other studies (Malmborg 
and Magnér, 2015; Radjenović et al., 2009; Ternes et al., 2005). Besides, the RSD of most 
OMPs in the liquid phase were inside this variation range, only some compounds (musk 
fragrances, NP, FLX, and E2) showed higher RSD due to their low recoveries, suggesting 
that the determination of these OMPs in the liquid phase is semiquantitative.  
5 
S2. Estrogenic Activity 
Figure S2 represents an example (first sampling campaign) of the calibration curve of the 
estrogenic assay, between RLU (Relative Light Units) normalized towards protein 
content and estradiol equivalent concentration (EEQ). The calibration curve shows a 
typical dose-response pattern (R2=0.92) between the estrogenic activity (response) and 
the E2 concentration (dose), whose main parameters are presented in Table S2. The 
consistency of cell responsiveness can be highlighted: the estrogenicity increased from a 
concentration of 100 fM-E2 up to 1 nM-E2 (representing the upper asymptote).  
 
Figure S2. Calibration curve for the estrogenic biological assay performed for the 
sampling campaign of Period I.  
Table S2. Main parameters derived from cell responsivity tests of the first sampling 







Control (MCF7 cells alone) 3.1 ‒ 
LOQ Lower 4.3 0.016 
Upper 9.7 ≈ 1,000 
EC50  (95% confidence interval) ‒ 3.1 (0.5, 18.9) 
LOQ, limit of quantification; EC50, half maximal effective concentration 
 























S3. Concentration of OMPs in sludge  
Table S3a. Total (Ct), liquid (Cw) and solid (Cs) phase average concentrations of OMPs in the mixed sewage sludge and in the digestates of the 
mesophilic (MAD) and thermophilic (TAD) digesters during Period I. 
 
LOQ, limit of quantification; n.a., not available.  
HHCB 9.20 ± 0.62 4055 ± 275 131 ± 9 141 ± 9 6.91 ± 0.44 3392 ± 216 86.5 ± 5.5 93.4 ± 5.5 9.79 ± 2.26 3701 ± 714 113 ± 23 122 ± 23
AHTN 2814 ± 330 91.3 ± 10.7 91.3 ± 10.7 2472 ± 168 63.0 ± 4.3 63.0 ± 4.3 2882 ± 183 88.0 ± 5.8 88.0 ± 5.8
CBZ 0.176 ± 0.004 7.62 ± 0.79 0.247 ± 0.026 0.423 ± 0.026 0.140 ± 0.004 5.49 ± 2.53 0.140 ± 0.065 0.280 ± 0.065 0.179 ± 0.017 7.47 ± 0.76 0.190 ± 0.024 0.369 ± 0.029
DZP
CTL 0.719 ± 0.070 55.2 ± 8.6 1.79 ± 0.28 2.51 ± 0.29 0.033 ± 0.001 28.9 ± 1.3 0.737 ± 0.032 0.770 ± 0.032 0.057 ± 0.034 39.0 ± 5.4 1.19 ± 0.17 1.25 ± 0.18
FLX 0.126 ± 0.012 74.3 ± 6.9 2.41 ± 0.22 2.53 ± 0.22 0.031 ± 0.005 31.6 ± 5.7 0.806 ± 0.144 0.837 ± 0.145 0.114 ± 0.021 81.4 ± 12.0 1.02 ± 0.38 1.13 ± 0.38
IBP 9.84 ± 0.96 487 ± 12 15.8 ± 0.4 25.6 ± 1.0 8.67 ± 0.69 388 ± 7 9.90 ± 0.17 18.6 ± 0.7 7.71 ± 0.19 448 ± 3 13.7 ± 0.1 21.4 ± 0.2
NPX
ROX 0.006 ± 0.002 1.81 ± 0.46 0.059 ± 0.015 0.065 ± 0.015 0.012 ± 0.007 3.86 ± 0.44 0.098 ± 0.011 0.110 ± 0.013 0.023 ± 0.005 9.95 ± 0.00 0.092 ± 0.000 0.116 ± 0.005
SMX
TMP 0.264 ± 0.016 12.2 ± 2.4 0.397 ± 0.078 0.661 ± 0.079 0.025 ± 0.001 2.14 ± 0.74 0.055 ± 0.019 0.080 ± 0.019 0.027 ± 0.009 2.45 ± 0.68 0.074 ± 0.022 0.101 ± 0.023
TCS 549 ± 32 14.7 ± 0.8 14.7 ± 0.8 838 ± 61 25.8 ± 1.9 25.8 ± 1.9
E1 1.04 ± 0.02 230 ± 144 7.46 ± 4.67 8.50 ± 4.67 5.89 ± 0.03 338 ± 80 8.6 ± 0.0 14.5 ± 2.0 2.44 ± 2.36 210 ± 45 6.24 ± 1.42 8.46 ± 2.75
E2 0.056 ± 0.011 18.0 ± 4.3 0.583 ± 0.140 0.640 ± 0.140 0.897 ± 0.126 220 ± 31 5.61 ± 0.79 6.51 ± 0.18 0.500 ± 0.107 83.9 ± 2.8 2.65 ± 0.09 3.15 ± 0.15




<LOQ <LOQ <LOQ <LOQ
<LOQ
<LOQ
<LOQ <LOQ <LOQ <LOQ
<LOQ <LOQ <LOQ
<LOQ <LOQ <LOQ <LOQ<LOQ <LOQ <LOQ <LOQ <LOQ
<LOQ
<LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ
<LOQ
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Table S3b. Total (Ct), liquid (Cw) and solid (Cs) phase average concentrations of OMPs in the mixed sewage sludge and in the digestates of the 
mesophilic (MAD) and thermophilic (TAD) digesters during Period II. 
 
LOQ, limit of quantification. 
HHCB 4975 ± 574 141 ± 16 141 ± 16 13922 ± 1782 192 ± 25 192 ± 25 6814 ± 1253 110 ± 20 110 ± 20
AHTN 1272 ± 87 36.1 ± 2.5 36.1 ± 2.5 7318 ± 796 101 ± 11 101 ± 11 3661 ± 661 59.3 ± 10.7 59.3 ± 10.7
CBZ 0.318 ± 0.039 158 ± 24 4.48 ± 0.67 4.80 ± 0.67 0.728 ± 0.326 136 ± 8 1.87 ± 0.10 2.60 ± 0.34 0.611 ± 0.116 114 ± 10 1.85 ± 0.15 2.47 ± 0.19
DZP 0.434 ± 0.054 131 ± 105 3.72 ± 2.99 4.16 ± 2.99 1.05 ± 0.21 79.9 ± 8.2 1.10 ± 0.11 2.15 ± 0.24 0.965 ± 0.140 68.1 ± 4.6 1.10 ± 0.07 2.07 ± 0.16
CTL 122 ± 13 3.48 ± 0.38 3.48 ± 0.38 137 ± 2 1.89 ± 0.03 1.89 ± 0.03 105 ± 4 1.69 ± 0.07 1.69 ± 0.07
FLX 0.062 ± 0.024 426 ± 318 12.1 ± 9.0 12.2 ± 9.0 0.101 ± 0.031 279 ± 99 3.85 ± 1.36 3.95 ± 1.36 0.414 ± 0.140 114 ± 10 1.85 ± 0.16 2.26 ± 0.25
IBP 4.33 ± 0.29 264 ± 97 7.50 ± 2.75 11.8 ± 2.8 6.15 ± 1.62 133 ± 32 1.83 ± 0.44 7.98 ± 1.68 6.09 ± 0.48 64.7 ± 16.7 1.05 ± 0.27 7.14 ± 0.55
NPX 0.586 ± 0.191 0.586 ± 0.191
ROX 64.8 ± 35.6 1.84 ± 1.01 1.84 ± 1.01 18.7 ± 2.1 0.258 ± 0.028 0.258 ± 0.028 9.01 ± 1.98 0.15 ± 0.03 0.146 ± 0.032
SMX 626 ± 160 17.8 ± 4.6 17.8 ± 4.6 273 ± 31 3.77 ± 0.43 3.77 ± 0.43 95.9 ± 24.0 1.55 ± 0.39 1.55 ± 0.39
TMP 0.273 ± 0.004 235 ± 15 6.66 ± 0.42 6.94 ± 0.42 0.242 ± 0.112 174 ± 21 2.40 ± 0.30 2.64 ± 0.32 0.297 ± 0.056 161 ± 9 2.61 ± 0.14 2.91 ± 0.15
TCS 1418 ± 181 38.1 ± 5.1 38.1 ± 5.1 2227 ± 216 32.3 ± 3.0 32.3 ± 3.0 1886 ± 471 30.9 ± 7.6 30.9 ± 7.6
E1 0.934 ± 0.116 128 ± 2 3.64 ± 0.05 4.57 ± 0.16 0.604 ± 0.331 488 ± 25 6.7 ± 0.3 7.3 ± 0.5 0.521 ± 0.026 274 ± 22 4.44 ± 0.36 4.96 ± 0.36
E2 0.097 ± 0.004 40.1 ± 20.1 1.14 ± 0.57 1.24 ± 0.57 0.252 ± 0.017 549 ± 5 7.57 ± 0.07 7.82 ± 0.07 0.103 ± 0.014 36.4 ± 2.2 0.590 ± 0.035 0.694 ± 0.038










Sewage Sludge MAD TAD 

















S4. Anaerobic digesters performance 
 
Figure S4. Organic loading rate (OLR) and methane production rate in the mesophilic (MAD) and 
thermophilic (TAD) digester. The grey sections represent the operation of the digesters during the 
monitoring campaigns of Period I and Period II.   
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S5. Influence of operational parameters on the biotransformation of OMPs 
 
Figure S5a. Average biotransformation (Period I and Period II) of OMPs in the mesophilic (MAD) 
and thermophilic (TAD) digesters. 
 
Figure S5b. Average biotransformation (MAD and TAD) during the first (Period I) and the second 
(Period II) monitoring campaigns. 
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S6. Distribution of OMPs between the liquid and solid phases of sludge  
 
Figure S6. Representation of OMPs partition between solid and liquid phase, through log Kd values, 
in the mixed sewage sludge (SS) and in the digested sludge by the average of MAD and TAD (AD). 
Asterisks refer the minimum values of log Kd calculated with the LOQ (AHTN, TCS, and SMX were 
only measured in solid phase; NPX was entirely in the liquid phase). 
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S7. Estrogenic activity of sludge  
 
Figure S7. Estrogenic activity exerted by sludge samples in the second sampling campaign (Period 
II), expressed as estradiol equivalent concentration. Values report the mean of 3 replicates, together 
































Liquid phase Solid phase
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S8. Ames test  
Table S8a. Ames test: mutagenicity expressed as revertants/plate (mean and standard deviation) and mutagenicity ratio (revertants number in the 





Period I Period II 















1  18.5 ± 6.4 0.98 21.5 ± 7.8 0.67 16.5 ± 2.1 1.06 25.0 ± 0.0 0.90 
10  21.5 ± 3.5 1.14 20.0 ± 1.4 0.62 21.5 ± 4.9 1.39 23.3 ± 0.8 0.83 
25  20.5 ± 3.5 1.09 22.0 ± 1.4 0.68 15.0 ± 0.0 1.97 27.0 ± 0.0 0.97 
50  22.0 ± 5.7 1.17 18.5 ± 4.9 0.58 n.a. n.a. 27.0 ± 0.0 0.97 
MAD 
 
1  16.5 ± 2.1 0.88 27.5 ± 2.1 0.85 16.0±7.1 1.03 28.0±4.2 1.01 
10  19.0 ± 4.2 1.01 24.0 ± 1.4 0.75 16.0±0.0 1.03 27.5±0.7 0.99 
25  Tox Tox 25.5 ± 3.5 0.79 14.0±0.0 0.90 25.0±0.0 0.90 
50  Tox Tox 21.0 ± 0.0 0.65 n.a. n.a. 19.0±0.0 0.68 
TAD 
 
1  13.0 ± 0.0 0.7 29.5 ± 2.1 0.92 22.0±4.2 1.42 29.5±7.8 1.06 
10  21.0 ± 4.2 1.1 30.0 ± 4.2 0.93 13.0±4.2 0.84 28.0±4.2 1.01 
25  15.0 ± 5.7 0.8 20.5 ± 4.9 0.64 23.0±0.0 1.48 32.0±0.0 1.15 
50  Tox Tox 25.0 ± 1.4 0.78 n.a. n.a. 26.0±0.0 0.94 
Control - 18.8 ± 5.3 32.3 ± 5.2 15.5 ± 1.9 27.8 ± 2.5 
Control + 667 ± 26.9 934.9 ± 98.9 >1000 >1000 
Negative control: 100 µl/plate DMSO; Positive control: 10 µg/plate 2-nitrofluorene for TA98-S9 and 10 µg/plate 2-aminofluorene for TA98+S9.  




Table S8b. Ames test: mutagenicity expressed as revertants/plate (mean and standard deviation) and 
mutagenicity ratio (revertants number in the sample/revertants number in negative control) for liquid 













1 18.5 ± 0.7 1.09 23.0 ± 0.0 0.85 
5 25.0 ± 4.2 1.47 28.5 ± 2.1 1.06 
10 22.0 ± 1.4 1.29 29.5 ± 2.1 1.09 
25 15.0 ± 0.0 0.88 32.0 ± 7.1 1.19 
50 Tox Tox 26.0 ± 0.0 0.96 
MAD 
1 17.0 ± 4.2 1.00 26.0 ± 5.7 0.96 
5 19.5 ± 6.4 1.15 32.5 ± 0.7 1.20 
10 20.5 ± 4.9 1.21 19.0 ± 4.2 0.70 
25 18.0 ± 2.8 1.06 28.0 ± 5.7 1.04 
50 16.0 ± 0.0 0.94 30.0 ± 0.0 1.11 
TAD 
1 22.0 ± 1.4 1.29 28.5 ± 4.9 1.06 
5 13.5 ± 0.7 0.79 24.0 ± 5.7 0.89 
10 19.0 ± 0.0 1.12 25.5 ± 3.5 0.94 
25 18.0 ± 0.0 1.06 19.5 ± 0.7 0.72 
50 Tox Tox 14.0 ± 0.0 0.52 
Control - 17.0 ± 2.9 27.0 ± 6.4 
Control + >1000 >1000 
 
Negative control: 100 µl/plate DMSO; Positive control: 10 µg/plate 2-nitrofluorene for TA98-S9 and 10 µg/plate 2-
aminofluorene for TA98+S9. 





S9. Comet test 
Table S9. Comet test results on solid phase samples for the two monitoring campaigns expressed as 




Period I Period II 
Visual score Tail Intensity Visual score Tail Intensity 




0.5  148 ± 8** 3.99 ± 1.80 147 ± 4* 3.83 ± 0.76 
1  159 ± 12*** 5.13 ± 2.09** 171 ± 13*** 7.58 ± 2.28*** 
5  Tox Tox Tox Tox 
10  Tox Tox Tox Tox 
25  Tox Tox Tox Tox 




0.5  126 ± 6 1.54 ± 0.57 127 ± 1 1.37 ± 0.70 
1  143 ± 11** 2.81 ± 2.45 145 ± 7* 2.86 ± 1.47 
5  159 ± 7*** 5.29 ± 0.58* 206 ± 6*** 12.2 ± 1.2 *** 
10  188 ± 8*** 8.62 ± 1.98*** 273 ± 19 *** 22.5 ± 2.0 *** 
25  Tox Tox Tox Tox 
50  Tox Tox Tox Tox 
TAD 
 
0.5  122 ± 3 2.36 ± 0.35 128 ± 6 1.41 ± 0.75 
1  145 ± 7 3.18 ± 1.42 141 ± 7*** 2.77 ± 1.30** 
5  159 ± 1 5.36 ± 1.65 166 ± 0*** 5.23 ± 1.25*** 
10  247 ± 54*** 19.7 ± 8.1*** 247 ± 4*** 16.2 ± 1.7*** 
25  275 ± 10 *** 24.2 ± 5.7*** 309 ± 0*** 29.9 ± 0.0*** 
50  328 ± 20*** 29.2 ± 4.2*** Tox Tox 
Negative control 117±4 0.80 ± 0.00 118 ± 0 0.86 ± 0.22 
* statistical significance vs negative control: p < 0.05 in accordance with Dunnett test 
** statistical significance vs negative control: p < 0.01 in accordance with Dunnett test 
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